OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Restriction point regulation at the crossroads between quiescence and cell proliferation
Betheney R. Pennycook, Alexis R. Barr
FEBS Letters (2020) Vol. 594, Iss. 13, pp. 2046-2060
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Cell cycle control in cancer
Helen K. Matthews, Cosetta Bertoli, Robertus A.M. de Bruin
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 74-88
Open Access | Times Cited: 965

Integrating Old and New Paradigms of G1/S Control
Seth M. Rubin, Julien Sage, Jan M. Skotheim
Molecular Cell (2020) Vol. 80, Iss. 2, pp. 183-192
Open Access | Times Cited: 207

A unified model for the G1/S cell cycle transition
Samuel Hume, Grigory L. Dianov, Kristijan Ramadan
Nucleic Acids Research (2020) Vol. 48, Iss. 22, pp. 12483-12501
Open Access | Times Cited: 144

Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 62

Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis
Sukanya Basu, Dong Yang, Rahul Kumar, et al.
Seminars in Cancer Biology (2021) Vol. 78, pp. 90-103
Open Access | Times Cited: 87

CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transition
Sung Soo Kim, Alessandra Leong, Minah Kim, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 55

A cell cycle centric view of tumour dormancy
William Weston, Alexis R. Barr
British Journal of Cancer (2023) Vol. 129, Iss. 10, pp. 1535-1545
Open Access | Times Cited: 27

The NUCKS1-SKP2-p21/p27 axis controls S phase entry
Samuel Hume, Cláudia P. Grou, Pauline Lascaux, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48

Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics
Lucía Gutiérrez-Chamorro, Eudald Felip, Ifeanyi Jude Ezeonwumelu, et al.
Trends in Microbiology (2021) Vol. 29, Iss. 9, pp. 836-848
Closed Access | Times Cited: 41

Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
Betheney R. Pennycook, Alexis R. Barr
Open Biology (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 38

Structure-guided design and development of cyclin-dependent kinase 4/6 inhibitors: A review on therapeutic implications
Mohd Yousuf, Manzar Alam, Anas Shamsi, et al.
International Journal of Biological Macromolecules (2022) Vol. 218, pp. 394-408
Closed Access | Times Cited: 25

Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism
Yiqing Gu, Qi Zheng, Guifang Fan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11042-11042
Open Access | Times Cited: 25

Cyclers’ kinases in cell division: from molecules to cancer therapy
Giacomo Milletti, Valeria Colicchia, Francesco Cecconi
Cell Death and Differentiation (2023) Vol. 30, Iss. 9, pp. 2035-2052
Open Access | Times Cited: 14

A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle
Hongli Li, Lulu Dong, Min-Jie Jin, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1141-1141
Open Access | Times Cited: 11

Modulation of Cell Cycle Kinases by Kaposi's Sarcoma‐Associated Herpesvirus
Steven Longworth, Blossom Damania
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Closed Access

Targeting CDK4/6 in breast cancer
Anusha Shanabag, Jessica Armand, Eugene Son, et al.
Experimental & Molecular Medicine (2025)
Open Access

Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
Qi Hao, Wenzhe Zhao, Zhijia Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117465-117465
Closed Access

Mechanisms of signalling-memory governing progression through the eukaryotic cell cycle
Béla Novák, John J. Tyson
Current Opinion in Cell Biology (2021) Vol. 69, pp. 7-16
Open Access | Times Cited: 25

When yeast cells change their mind: cell cycle “Start” is reversible under starvation
Deniz Irvali, Fabian P. Schlottmann, Prathibha Muralidhara, et al.
The EMBO Journal (2022) Vol. 42, Iss. 2
Open Access | Times Cited: 16

Advances in the Anti-Tumor Activity of Biflavonoids in Selaginella
Mengdie Ren, Sihui Li, Qiong Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7731-7731
Open Access | Times Cited: 10

Cell cycle regulation by complex nanomachines
Marios G. Koliopoulos, Claudio Alfieri
FEBS Journal (2021) Vol. 289, Iss. 17, pp. 5100-5120
Open Access | Times Cited: 19

Effect of Titanium Dioxide Nanoparticles on Mammalian Cell Cycle In Vitro: A Systematic Review and Meta-Analysis
Hongmei Chang, Qianqian Wang, Xiaojia Meng, et al.
Chemical Research in Toxicology (2022) Vol. 35, Iss. 9, pp. 1435-1456
Closed Access | Times Cited: 13

Page 1 - Next Page

Scroll to top